Objectives: A rapid, sensitive and selective analytical method has been developed and validated by liquid chromatography tandem Mass spectrometry (LC-MS/MS) for the quantification of traces of Cumene Hydroperoxide in Esomeprazole magnesium trihydrate active pharmaceutical ingredient. Materials and Methods: The chromatographic separation was carried out on a Develosil Phenyl phase-UG-5 150 x 4.6mm, 3μm column. The mobile phase consisting of 1% Ammonia solution buffer and acetonitrile, the flow rate was 0.9 mL/min with isocratic elution. Results: The retention time of Cumene Hydroperoxide was found 9.25 mins. The developed method was validated according to ICH guidelines. The system suitability was found 4.8% RSD and the linearity calibration curve was linear over the concentration range of 2.309 ppm to 12.747 ppm (r = 0.999). The intraday and inter-day precision (RSD %) was 2.1% and the obtained recovery (%) was at LOQ to 150% is in between 92.4% to 102.8% respectively. Conclusion: The low RSD values and high recoveries of the method confirms the suitability of the method for quantification of Cumene Hydroperoxide in Esomeprazole magnesium trihydrate API.
INTRODUCTION
Synthesis of active pharmaceutical ingredients often involves the use of reactive substances and hence, these reactive substances may be extant in the final drug substances as impurities. Such chemically reactive impurities may have unwanted toxicities, including carcinogenicity and genotoxicity and these impurities are to be controlled based on the maximum daily dose. 1 These limits normally fall at low μg/mL levels and hence conservative GC, HPLC methods (or final drug substance methods) are not suitable for their determination. Sophisticated techniques like LC-MS combine physical separation competences of chromatography (HPLC) with the mass analysis competences of mass spectrometry and have specificity and high sensitivity over conser-vative HPLC method. Their applications are oriented towards the potential identification and quantitation of trace level of impurities in drug substances. 2 Cumene hydroperoxide 3 is genotoxic, including DNA damage and mutations in prokaryote systems. DNA single strand breaks were included in isolated rat hepatic nuclei, but single or double strand breaks were not induced in the DNA of lysed human adenocarcinoma cells. Cumene hydroperoxide enhanced asbestos-induced damage in calf thymus DNA. Cumene hydroperoxide is relatively stable organic peroxide. It is typically used as an oxidizing agent. Its formula is C 6 H 5 C (CH 3 ) 2 OOH and chemical structure is depicted in Figure 1 . Cumene hydroperox-ide available with a purity of ~80% in commercial market. Esomeprazole is the enantiomer of omeprazole. Chemically it is 5-Methoxy-2-(S) [(4-methoxy-3, 5-dimethyl-2-pyridinyl) methyl] sulfinyl]-1H-benzimidazole magnesium salt trihydrate with molecular formula C 34 H 3 6 MgN 6 O 6 S 2 •3H 2 OC 17 H 18 N 3 O 3 S•Na and chemical structure depicted in Figure 2 . Esomeprazole is cost effective in treatment of gastric oesophageal reflux diseases. 4 Esomeprazole magnesium was developed as the S-isomer of omeprazole as an attempt to improve its pharmacokinetic properties. 5 Esomeprazole is highly bound (97%) to plasma proteins and primarily metabolized by 2 cytochrome P450 (CYP) isozymes, CYP3A4 and CYP2C19, with CYP2C19 being the predominant metabolic pathway. 6 There are stereo selective differences in the metabolism of PPIs by the cytochrome P450 (CYP) isoenzymes 2C19 and 3A4 and this is the basis of the observed pharmacodynamic and clinical efficacy differences between Esomeprazole and omeprazole. Literature survey reveals that very few analytical methods have been established for the determination of Esomeprazole 7-9 and Cumene hydroperoxide. 10 To the best of our knowledge, there is no reported LC-MS/ MS method for determination of Cumene Hydroper-oxide in Esomeprazole magnesium trihydrate active drug, previous to our work. Thus, efforts were made to develop fast, selective and sensitive analytical method for the determination of Cumene Hydroperoxide in Esomeprazole magnesium trihydrate raw material by using LC-MS/MS. In the current work, developed and validated 11 a simple, reliable and reproducible LC-MS/ MS method, which was duly validated by statistical parameters like, precision, accuracy and recovery.
MATERIALS AND METHODS

Esomeprazole magnesium trihydrate and Cumene
Hydroperoxide was the generous gift from Everest organics limited, Hyderabad, India. HPLC grade acetonitrile and Methanol was procured from Qualigens, India. Ammonia solution and Formic acid were purchased from Loba Chemie, Mumbai, India. All other chemicals and solvents used analytical grade. Water used in the LC-MS/MS analysis was prepared by the water purifier (Arium ® , 611UF, Sartorius, Germany). The mobile phase solution was filtered through a 0.45 μm Ultipor ® N66 ® membrane filter (Pall Life Sciences, USA) prior to use. 
Instrumentation and Chromatographic conditions
Preparation of solution A
Use buffer
Preparation of solution B
Prepare a mixture of buffer and acetonitrile in the ratio of 10:90 (%v/v)
Preparation of mobile phase
Prepare a mixture of solution A and solution B in the ratio of 25:75 (%v/v) Preparation of diluent 0.25% formic acid in methanol.
Preparation of Cumene Hydroperoxide standard stock solution
Weigh accurately and transfer about 10.0 mg of Cumene Hydroperoxide standard into 100 mL volumetric flask, dissolve and dilute the volume with diluent and mix well. Transfer 2.55 mL of above solution into a 100 mL volumetric flask and dilute the volume with diluent and mix well.
Preparation of Cumene Hydroperoxide standard solution
Transfer 5.0 mL of above Cumene Hydroperoxide standard stock solution into a 50 mL volumetric flask and dilute the volume with diluent and mix well.
Preparation of test solution
Weigh accurately and transfer about 150 mg of test sample into 5 mL volumetric flask, dissolve and dilute the volume with diluent then sonicate and mix well.
Specification
Not more than 8.5 ppm
Method validation
The developed method was validated as per United States Pharmacopoeia general chapter <1225> 12 and ICH Q2 (R1) guidelines
System suitability
The system suitability test was performed using six replicate injections of standard and evaluated the system suitability.
Specificity
The method was validated for specificity by injecting diluent as a blank solution in triplicate and evaluated for blank peaks interference at the retention time of Cumene Hydroperoxide (Mass:135.16).
Precision
Precision of the method was evaluated by injecting the six impurity spiked test samples preparations from a homogeneous Esomeprazole magnesium trihydrate API. The % relative standard deviation of six spiked test samples was calculated for Cumene Hydroperoxide. Intermediate precision of the method was also evaluated as same like precision by using different instru-ment and different column by injecting the six impurity spiked test samples preparations.
Limit of detection and limit of quantification
The LOD and LOQ are expressed as a known concentration of Cumene Hydroperoxide at a specified signal to noise ratio, usually for LOQ 10:1, for LOD 3:1 can be quantitated and detected under the stated LC/MS method.
Linearity
Linearity was conducted by preparing the six levels of linearity solutions for Cumene hydroperoxide from the range of LOQ (2.309 ppm) level to 150% (12.747 ppm) level. The pure form of Cumene Hydroperoxide was used to prepare the linearity solutions. Draw a linearity graphs for the peak area against concentration.
Accuracy
The recovery of the method was evaluated by spiking the Cumene Hydroperoxide in test sample at the concentration of LOQ, 50%, 100% and 150% of the specification level. The recovery samples were prepared in triplicate at each level and injected in the proposed LC-MS/MS method. The % recovery of Cumene Hydroperoxide was calculated at each level. The acceptance limit for recovery of Cumene Hydroperoxide was 90.0 to 110.0%.
Solution stability
The bench top stability of Cumene hydroperoxide standard and spiked sample preparation established up to 12 hrs, after preparation (n = 1) at bench top condition. Solution stability was evaluated by similarity of standard and % absolute difference of test sample.
Robustness
The robustness of the method was evaluated by deliberately altering the method conditions from the original method parameters on same concentration of the Cumene hydroperoxide. Test sample was analyzed with three different preparations. Robustness of the method was assessed by varying the instrumental conditions such as flow rate (± 10%) and column temperature (± 5°C). The robustness study was evaluated by the calculation of the % content of Cumene hydroperoxide in spiked sample.
RESULTS AND DISCUSSION
Method development
Initially the method was developed on HPLC by using the mixture of ammonia buffer and acetonitrile in the ratio of 70:30 as a mobile phase with 1.2mL flow rate by using 257nm with UV Detector. In the HPLC method the response of Cumene hydroperoxide at specification level was very low and the obtained area response was not sufficient and not reproducible for the quantifying the Cumene hydroperoxide and alternatively developed and optimized a liquid chromatography tandem Mass spectrometry (LC-MS/MS) with using of 1% Ammonia solution buffer and acetonitrile as mobile phase and phenyl phase column with Mass detector and the obtained area response was reproducible and the retention time of the Cumene Hydroperoxide was about 9.25 min.
System suitability
The system suitability of the method was demonstrated by means of % RSD of area of six replicate standards. The obtained results of % RSD for six replicates of Cumene hydroperoxide peak area from standard was less than 5.0%. System suitability parameter results are presented in Table 1 .
Specificity
Specificity study was performed to check the no interference of blank peaks at the retention time of Cumene Hydroperoxide. The chromatograms of blank, standard, test sample and spiked test sample were shown in Figure 3 -6 respectively, no blank peaks are present at the retention time of Cumene hydroperoxide.
Precision
Precision of the method was evaluated by injecting the six impurity spiked test samples preparations from a homogeneous Esomeprazole magnesium trihydrate API. The % relative standard deviation of six spiked test samples from precision and intermediate precision study was 1.3 and 1.1 respectively. The cumulative % RSD of Method precision and intermediate precision with respect to test concentration. The Chromatograms for Detection limit and Quantification limit level were shown in Figure 8 and Figure 9 respectively.
Linearity
Linearity was conducted by preparing the six levels of linearity solutions and found linear from LOQ (2.309 ppm) level to 150% (12.747 ppm) level for Cumene hydroperoxide. Drawn a linearity graph for Cumene Hydroperoxide peak area against its concentration and linearity graphs shown in Figure 10 and linearity data is presented in Table 2 . study was 1.2. The graphical presentation of Precision and Intermediate precision study shown in Figure 7 .
Limit of detection and limit of quantification
The LOD and LOQ values are established by signal to noise ratio method, the obtained S/N value of Cumene hydroperoxide were 10.9 at LOQ concentration 2.309 ppm, 3.6 at LOD concentration 0.0775 ppm 
Accuracy
The accuracy was evaluated by spiking the Cumene hydroperoxide in sample solution corresponding at LOQ, 50%, 100% and 150% of specification level. Three spiked samples were prepared at 50% and 100% levels and six spiked samples were prepared at LOQ and 150% level of specification. Each spiked sample solution was injected and all the found results were satisfactory and the results are presented in Table 3 .
Solution stability
The bench top stability of Cumene hydroperoxide standard and spiked sample established up to 12 hr and both standard and test sample stable up to 12 hr. Similarity factor of standard at 12 hr was found 0.99 and the abso- lute difference of Cumene Hydroperoxide content in ppm was with in the 0.20% Absolute difference.
Robustness
Robustness of the method was assessed by varying the instrumental conditions such as flow rate (± 10%) and column temperature (± 5°C). The deliberate changes in the method have no significant changes in the % content of Cumene hydroperoxide in spiked sample. The robustness results were presented in Table 4 .
CONCLUSION
The developed and validated method is simple, sensitive, innovative and economical method for determine the low level Cumene Hydroperoxide content by liquid chromatography tandem Mass spectrometry (LC-MS/ MS). The validation study performed as per USP and ICH guidelines and it revealed that the method is specific, linear, precise, accurate and robust over the range of 2.309 ppm to 12.747ppm. Hence it is concluded that the proposed method can be used for routine and stability analysis in quality control laboratories in pharmaceutical industries.
